Allotment

Bio Medica Laboratories IPO will open on May 21, 2026 and will close on May 25, 2026. This IPO is a book-built issue, where the company aims to raise around ₹[.] crores. The issue includes a fresh issue of ₹[.] crores along with an offer for sale of up to 3,76,800 equity shares having a face value of ₹10 each.
The price band for Bio Medica Laboratories IPO has been fixed at ₹[.] to ₹[.] per share. The quota allocation consists of 35% for retail investors, 50% for QIBs, and 15% for HNIs. The IPO is scheduled to be listed on NSE on May 28, 2026, while the allotment date is expected on May 26, 2026.
In terms of financial performance, the company reported revenue of ₹38.33 crores in 2025 against ₹15.34 crores in 2024. The company reported profit of ₹9.79 crores in 2025 compared to profit of ₹2.50 crores in 2024. As per the financials, investors may consider applying to the IPO for a long-term perspective.
₹1120%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 28 May |
| IPO Listing Date | 28 May |
| IPO Face Value | ₹10 Per Equity Share |
| IPO Price Range | ₹00.00 |
| IPO Issue Size | 37,71,600 Equity Shares |
| IPO Sale Type | Fresh Capital |
| Employee Discount | - |
| IPO Issue Type | Book build Issue |
| IPO Listing | NSE SME Platform |
| Share Holding Pre Issue | 91,80,001 shares |
| IPO Open Date | 21 May |
| IPO Close Date | 25 May |
| IPO Allotment (Tentative) | 26 May |
| Refunds | 27 May |
| Credit to Demat Account | 27 May |
| IPO Listing Date | 28 May |
| Category | Offer |
|---|---|
| QIB Shares Offered | - |
| NII (HNI) Shares Offered | - |
| Retail Shares Offered | - |
–
| Application | Lots | Share | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | - | - | - |
| Individual investors (Retail) (Max) | - | - | - |
| S-HNI (Min) | - | - | - |
| S-HNI (Max) | - | - | - |
| B-HNI (Min) | - | - | - |
BIO MEDICA LABORATORIES LIMITED is a leading parenteral manufacturing company based in Central India, known for its strong focus on quality, innovation, and healthcare excellence. The company specializes in producing a wide range of parenteral formulations, including injectables for human and veterinary applications. Built on a foundation of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), BIO MEDICA ensures that every product meets strict international standards of safety, purity, and effectiveness. Its modern manufacturing facilities are equipped with advanced technology, enabling consistent production of high-quality injectable solutions for domestic as well as global markets.
The company offers a diverse portfolio of injectable products designed to meet the needs of hospitals, healthcare providers, and veterinary care sectors. With a growing export presence, BIO MEDICA LABORATORIES LIMITED continues to expand its global footprint by delivering reliable healthcare solutions worldwide. The organization is driven by a strong mission to improve health and well-being through innovative parenteral formulations for both humans and animals. Its vision is to become a globally recognized leader in the pharmaceutical manufacturing industry by maintaining excellence, sustainability, and continuous improvement in all aspects of its operations.
| Assets | 31.81 | 24.77 | 18.35 |
| Total Income | 105.35 | 102.06 | 66.37 |
| Profit After Tax | 9.04 | 8.22 | 4.64 |
| EBITDA | 12.4 | 10.86 | 6.04 |
| Net Worth | 23.37 | 14.34 | 6.12 |
| Reserves and Surplus | 10.75 | 14.29 | 6.07 |
| Total Borrowing | 3.62 | 5.05 | 4 |
| ROE | 99.59% |
| ROCE | 48.20% |
| Debt/Equity | 1.02 |
| RoNW | 99.59% |
| PAT Margin | 25.64% |
| EBITDA Margin | 39.83% |
| Price to book value | - |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | - |
| 3 | To meet out the General Corporate Purposes; | - |
| 4 | Offer for Sale (OFS) | - |
Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/
Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php